Focus group activities are carried out about below mentioned subject matters by Omega-APC.

• Local data acquisition for model adaptation

Determination and validation of the use of resources (specialist, consultation, intensive care, hospitalization, laboratory and diagnostic tests, drugs and care) for disease and adverse event management during the use of the molecule/drug in the relevant indication

• Prevalence and incidence analysis

Realization of the prevalence and incidence figures and prospective projections of the disease to be used for reimbursement application (with methodology and reference information)

• Patient number analysis

Determination of patient flow and number of patients in the relevant indication and at different stages

• Market share analysis

Determination of the market shares of molecules and their comparators in the relevant indication and in case of reimbursement/indication expansion